|
|
|
|
|
|
|
|
|
|
|
05.09.25 - 20:33
|
Kenvue Craters On Report RFK Jr To Link Autism To Tylenol Use In Pregnancy (ZeroHedge)
|
|
|
Kenvue Craters On Report RFK Jr To Link Autism To Tylenol Use In Pregnancy
The stock of Tylenol maker Kenvue is crashing after a WSJ report according to which Robert F. Kennedy Jr. plans to announce that pregnant women's use of an over-the-counter pain medication is potentially linked to autism in a report that will also suggest a medicine derived from folate can be used to treat symptoms of the developmental disorder in some people.
The report, sourced to "people familiar" and expected this month from the Department of Health and Human Services, is likely to highlight low levels of folate, an important vitamin, and Tylenol - which has been mass produced since 1955 - taken during pregnancy as well as other potential causes of autism.
Kennedy's department also plans to pinpoint a form of folate known as folinic acid, or leucovorin, the people said, as a way to decrease the symptoms of autism, which affected roughly one in 31 eight-year-olds in the U.S. in 2022.
Tylenol, whose active...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07.08.25 - 15:15
|
Kenvue (KVUE) Q2 Earnings Top Estimates (Zacks)
|
|
|
Kenvue (KVUE) delivered earnings and revenue surprises of +3.57% and -0.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...
|
|
|
|
|
|
|
07.08.25 - 13:48
|
Kenvue Inc. Announces Advance In Q2 Profit (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Kenvue Inc. (KVUE) revealed a profit for its second quarter that Increases, from last yearThe company's bottom line totaled $420 million, or $0.22 per share. This compares w......
|
|
|
|
|
07.08.25 - 12:51
|
Kenvue Reports Second Quarter 2025 Results (Business Wire)
|
|
|
Net Sales (4.0)%; Organic Sales1 (4.2)%
Diluted EPS was $0.22; Adjusted Diluted EPS1 was $0.29
Continues to Advance Ongoing Review of Strategic Alternatives, While Taking Actions to Accelerate Profitable Growth Under the New Executive Team
Revises Outlook for FY'25
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced financial results for the second quarter ended June 29, 2025.
“Kenvue has a strong portfolio of world-class, category-defining brands. We are actively focused on improving execution and performance, while advancing the comprehensive strategic alternatives review, to deliver our inherent value,” said Kirk Perry, Interim Chief Executive Officer. “I'm thrilled to take on this new role at such an important time for the Company and am committed to ensuring we have the right talent, brand portfolio, and operational foundation in place to accelerate profitable growth and best position Kenvue to realize its full potential.”
Second Quarter Summary
Net sales decreased 4.0% ...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
